Vinodh Pillai, MD, PhD
Associate Professor of Pathology and Laboratory Medicine at the Children's Hospital of Philadelphia
Perelman School of Medicine at the University of Pennsylvania
Contact InformationChildren's Hospital of Philadelphia
Department of Pathology and Laboratory Medicine
Philadelphia, PA, 19104
Fax: 215-590-1736
Research Expertise
CAR T cell therapy
Acute lymphoblastic leukemia
Castleman disease
Kikuchi-Fujimoto lymphadenitis
Single cell sequencing of pediatric lymphoma
Spatial transcriptomics
Clinical Expertise
Hematopoietic neoplasms
Pathology of CAR T cell therapy in B-ALL
Education
M.B.B.S. (Medicine and Surgery), Madras Medical College, 2002
Ph.D. (Biomedical sciences, Immunology), University of Texas Southwestern Medical Center , 2007
Ph.D. (Machine Learning in Bioinformatics), Canadian Bioinformatics Workshops, 2026
Specialty Certification
American Board of Pathology (Anatomic and Clinical Pathology), 2013
American Board of Pathology (Hematology/Hematopathology), 2014
Postgraduate Training
Compulsory Rotatory Residential Internship , Government General Hospital, Madras, India, 2001-2002
Post-Doctoral fellow of the National Multiple Sclerosis Society, Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, 2007-2009
Anatomic and Clinical Pathology Residency, Brigham and Women’s Hospital, Boston, MA, 2009-2013
Hematopathology , Brigham and Women’s Hospital, Dana Farber Cancer Institute and Boston
Children's Hospital Boston, MA, 2013-2014
Awards and Honors
Top 5 Poster Award in GSO Poster Competition, 2005
Eliot Goldings Award for the Best Graduate Student in Immunology, 2007
Graduate Student Organization (GSO) Travel Award, 2007
BWH Biomedical Research Institute Microgrant Award, 2012
Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Physicians and Scientists, 2013
SIOP (International Society of Paediatric Oncology) Young Investigator Award, 2018
HTG EdgeSeq 2020 Autoimmune Panel Research Grant Award, 2020
Enid Gilbert Barness Prize - Society for Pediatric Pathology, 2022
Memberships and Professional Organizations
American Association of Immunologists, 2007 - 2009
Clinical Immunology Society, 2007 - 2009
United States and Canadian Academy of Pathology, 2011 - 2014
American Society for Clinical Pathology, 2012 - Present
Academy of Clinical Laboratory Physicians and Scientists, 2013 - 2015
International Clinical Cytometry Society, 2015 - present
Children's Oncology Group, 2015 - Present
Society for Hematopathology, 2015 - Present
Children's Oncology Group Young Investigator Mentorship Program, 2017 - Present
American Society for Clinical Oncology, 2018 - Present
College of American Pathologists, 2018 - Present
Perelman School of Medicine at the University of Pennsylvania, 2023 - 2023
Web Links
Selected Publications
Human GPR174 Deficiency Drives Lymphoproliferation Resembling Kikuchi-Fujimoto Disease via Defects in T Cell Function
Yun-Han Huang1,2*, Kathya Arana3,4*, Hanson Tam1, Jarmila Stremenova Spegarova5, Karin R. Engelhardt5, Helen Griffin5, Molly Mee5, Maurizio Miano6, Federica Raggi 6, Alice Grossi7, Marta Rusmini8, Isabella Ceccherini7, Gianluca Dell’Orso6, Jacopo Ferro9, Vinodh Pillai,10 Siddarth Banka11,12, Tomaz Garcez13, Tracy A. Briggs12, Fethi Mellouli14, Sandra von Hardenberg15,16, Rita Beier17, Bernd Auber15, Ulrich Baumann18, Hasan Tawamie19, Edward Behrens20,21, Emylette Cruz Cabrera4, Ying Xu1, Shinyi Ouyang1, Sophie Hambleton5, Neil Romberg4,20+, Jason Cyster1+, ACR Convergence 2026, 2026
A single-cell atlas of >1 million blood and lymph node immune cells reveals peripheral and tissue immune reprogramming following CD3×CD19 T-cell engager therapy in active SLE
Jason Xu¹,²,³#, Chunli Mei²#, Xin Guan²#, Rong Du², Bin Wu⁴, Di Wu², Mengjiao Li², Jingna Li², You Song², Hua Su⁵, Xiaoqi Chen⁶, Qianyu Guo⁷, Hanyang Chen⁸, Kenan Onel⁹, Tobias V. Lanz¹⁰,¹, Tamiko R. Katsumoto¹, Xiaoqiang Yan⁸, Kai Tan¹¹,¹², Caroline Diorio¹¹,¹², David T. Teachey¹¹,¹², Vinodh Pillai¹¹,¹², Gisselle Salmasi13, Andreas Kerschbaumer¹, Eric Meffre¹, Vanessa E. Kennedy14, William H. Robinson¹, Anbing Huang², Qiubai Li²* and Matthew C. Baker¹*, ACR Convergence 2026, 2026
Multi-lineage immune remodeling following CD3xCD19 T-cell engagement in active systemic lupus erythematosus: single-cell genomic results from a Phase I investigator initiated trial
Jason Xu1,2#, Chunli Mei2#, Xin Guan2#, Rong Du2#, Bin Wu3#, Di Wu2, Mengjiao Li2, Jingna Li2, You Song2, Hua Su4, Xiaoqi Chen5, Qianyu Guo6, Hanyang Chen7, Jonathan H. Sussman8,9, Gregory M. Chen8, Shovik Bandyopadhyay8,9, Vinodh Pillai9, Michaela Liedtke10, Kai Tan8,9, Caroline Diorio8,9, David T. Teachey8,9, Tobias V. Lanz11,12, Kenan Onel13, Gisselle Salmasi14, Tamiko R. Katsumoto11, William H. Robinson11, Andreas Kerschbaumer11, Eric Meffre11, Vanessa E. Kennedy10, Xiaoqiang Yan7, Anbing Huang2, Matthew C. Baker11* and Qiubai Li2*,, ACR Convergence 2026, 2026
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
Xu J, Mei C, Guan X, Du R, Wu B, Wu D, Li M, Li J, Song Y, Su H, Chen X, Guo Q, Chen H, Sussman J, Chen G, Liedtke M, Tan K, Onel K, Teachey D, Lanz T, Katsumoto T, Robinson W, Meffre E, Kennedy V, Yan X, Huang A, Baker M, Bandyopadhyay S, Pillai V, Salmasi G, Nature Medicine, 2026, PMID:6400537
How I diagnose Castleman disease
Dorottya Laczko; Vinodh Pillai; Dale Frank; Joshua D. Brandstadter; David C. Fajgenbaum, American Journal of Clinical Pathology 165(3): , 2026, PMID:41802815
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
Carturan A, Angelos MG, Guruprasad P, Patel RP, Pajarillo R, Lee AE, Espie D, Zhang Y, Chiang YH, Xie W, Rodriguez JL, Harris J, Devi P, Afolayan-Oloye OI, Xu J, Sussman JH, Elghawy O, Yang AG, Barsouk A, Cho JH, Shaw CE, Singh EB, Ugwuanyi O, Paruzzo L, Stella FMD, Liu S, Nason S, Imparato A, Rotolo A, Lemoine J, Barrett DM, Posey AD Jr, Rook AH, Pillai V, Bagg A, Pileri SA, Liu D, Tan K, Schuster SJ, Teachey DT, Porazzi P, Ruella M, Blood, 2026, PMID:41490267
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Ang Z, Castro A, Paruzzo L, Schmidt C, Hasanali ZS, Hayer KE, Stella F, Soldan SS, Torres-Diz M, Kwok C, Sainos PK, Ji K, Krohl PJ, Fine J, Sehgal P, Martinez D, Spangler JB, Riley JL, Vogl DT, Porazzi P, Pillai V, Lieberman PM, Allman D, Ruella M, Thomas-Tikhonenko A, bioRxiv, 2026, PMID:41648131
090 – Pediatric ALK-negative anaplastic large cell lymphoma genetically differs from the adult counterpart
James ER, Salmeron-Villalobos J, Colmenero A, Frauenfeld L, Andres M, Verdu J, Garcia N, Simonitsch-Klupp I, Attarbaschi A, Bacon CM, Burke GA, Lockhart B, Ducray SP, Chen Z, Tizioni MM, Matthews JD, Steel C, Pillon M, Lussolin A, Pervez S, Pillai V, Štěrba J, Krenova Z, Aven M, Wrobel G, Werner J, Knorr F, Oschlies I, Klapper W, Woessmann W, Balague O, Salaverria I, Turner SD, Leukemia Research 156(Supplement): Abstract 090, 2025
Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways
Smith D, Eichinger A, Fennell É, Xu-Monette ZY, Rech A, Wang J, Esteva E, Seyedian A, Yang X, Zhang M, Martinez D, Tan K, Luo M, Young KJ, Murray PG, Park C, Reizis B, Pillai V, Nat Commun 16(1): 6009, 2025, PMID:40593805
RNA-seq of seven non-neoplastic/inflammatory lymphadenitis entities identify potential molecular diagnostic markers
Julia Wang, Brian Lockhart, Jason Xu, Vinodh Pillai, bioRxiv, 2025


